Opin vísindi

Fletta eftir höfundi "Kostopoulou, Myrto"

Fletta eftir höfundi "Kostopoulou, Myrto"

Röðun: Raða: Niðurstöður:

  • Luxardo, Rosario; Kramer, Anneke; González-Bedat, Maria Carlota; Massy, Ziad A; Jager, Kitty J; Rosa-Diez, Guillermo; Noordzij, Marlies; Alvarez Estevez, Guillermo A.; Ambuhl, Patrice; Andrusev, Anton M; Fuster, Emma Arcos; Arribas Monzón, Federico E; Barbullushi, Myftar; Barreto, Susana; Buturovic-Ponikvar, J.; Boj, Julio; Cangiano, Jose L.; Caskey, Fergus J; de la Nuez, Pablo Castro; Cernevskis, Harijs; Collart, Frederic; Couchoud, Cécile; Elgueta, Susana; García, Guillermo García; Trabanino, Ramón García; Gârneaţă, Liliana; Golan, Eliezer; Gomez Acevedo, Rafael A.; Hemmelder, Marc H; Hernandez, Agualuz; Hernandez, Fabio; Ioannou, Kyriakos; Kolesnyk, Mykola; Kostopoulou, Myrto; Lopot, Frantisek; MacÁrio, Fernando; Mahillo-Duran, Beatriz; Maksimovic, Natasa; Marinovich, Sergio; Mendez, Orleans; Orduñez, Pedro; Ortiz, Fabian; Ortiz, Mireya; Pálsson, Runólfur; Pechter, Ülle; Pereda, Carlos; Perez-Oliva, Jorge; Pippias, Maria; Poblete, Hugo; Ratkovic, Marina; Resić, H.; Rodriguez, Gaspar; Rutkowski, Boleslaw; de Pablos, Carmen Santiuste; Sesso, Ricardo; Silva, Nica; Spustová, Viera; Traynor, Jamie P.; Valdez, Regulo; Valencia, Jose Luis; Waldum-Grevbo, Bård E.; Ziginskiene, Edita (2018)
    Objective: To compare the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in Latin America and Europe, as well as to study differences in macro-economic indicators, demographic and clinical patient characteristics, ...
  • Ocak, Gurbey; Boenink, Rianne; Noordzij, Marlies; Bos, Willem Jan W.; Vikse, Bjorn E.; Cases, Aleix; Kerschbaum, Julia; Helve, Jaakko; Nordio, Maurizio; Arici, Mustafa; Mercadal, Lucile; Wanner, Christoph; Palsson, Runolfur; Hommel, Kristine; De Meester, Johan; Kostopoulou, Myrto; Santamaria, Rafael; Rodrigo, Emilio; Rydell, Helena; Bell, Samira; Massy, Ziad A.; Jager, Kitty J.; Kramer, Anneke (2022-04-18)
    Importance: During the past decades, improvements in the prevention and management of myocardial infarction, stroke, and pulmonary embolism have led to a decline in cardiovascular mortality in the general population. However, it is unknown whether ...